GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Interest Expense

SyntekaBio (XKRX:226330) Interest Expense : ₩-2,465.7 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. SyntekaBio's interest expense for the three months ended in Mar. 2025 was ₩ -655.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-2,465.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. SyntekaBio's Operating Income for the three months ended in Mar. 2025 was ₩ -2,957.8 Mil. SyntekaBio's Interest Expense for the three months ended in Mar. 2025 was ₩ -655.5 Mil. SyntekaBio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


SyntekaBio Interest Expense Historical Data

The historical data trend for SyntekaBio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Interest Expense Chart

SyntekaBio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial -84.36 -254.17 -1,251.22 -375.74 -2,008.39

SyntekaBio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -198.18 -473.49 -659.94 -676.78 -655.50

SyntekaBio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,465.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SyntekaBio  (XKRX:226330) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SyntekaBio's Interest Expense for the three months ended in Mar. 2025 was ₩-655.5 Mil. Its Operating Income for the three months ended in Mar. 2025 was ₩-2,957.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ₩10.7 Mil.

SyntekaBio's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

SyntekaBio did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


SyntekaBio Business Description

Traded in Other Exchanges
N/A
Address
187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512
SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio Headlines

No Headlines